Literature DB >> 26292633

Occurrence of Sweet syndrome under anti-TNF.

Christopher Banse1, Valérie Sobocinski2, Guillaume Savoye3, Gilles Avenel4, Olivier Vittecoq4.   

Abstract

We report the occurrence of Sweet's syndrome in a patient treated with adalimumab for Crohn's disease. The imputability of adalimumab is at issue.

Entities:  

Keywords:  Adalimumab; Biotherapy; Neutrophilic dermatosis; Sweet syndrome

Mesh：

Substances：

Year:  2015        PMID： 26292633     DOI： 10.1007/s10067-015-3054-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  7 in total

1.  Paradoxical reactions to targeted biological treatments: A way to treat and trigger?

Authors:  Alexandra M G Brunasso; Martin Laimer; Cesare Massone
Journal:  Acta Derm Venereol       Date:  2010-03       Impact factor: 4.437

2.  Development of pyoderma gangrenosum during therapy with infliximab.

Authors:  Natalia Jaimes-López; Verónica Molina; Juan E Arroyave; Luz A Vasquez; Ana C Ruiz; Rodrigo Castaño; Mario H Ruiz
Journal:  J Dermatol Case Rep       Date:  2009-08-24

Review 3.  Neutrophilic dermatoses: part I.

Authors:  Renan Rangel Bonamigo; Fernanda Razera; Gislaine Silveira Olm
Journal:  An Bras Dermatol       Date:  2011 Jan-Feb       Impact factor: 1.896

Review 4.  Sweet's syndrome: a neutrophilic dermatosis classically associated with acute onset and fever.

Authors:  P R Cohen; R Kurzrock
Journal:  Clin Dermatol       Date:  2000 May-Jun       Impact factor: 3.541

5.  Diagnostic criteria for Sweet's syndrome.

Authors:  W P Su; H N Liu
Journal:  Cutis       Date:  1986-03

Review 6.  Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria.

Authors:  Angelo V Marzano; Rim S Ishak; Simone Saibeni; Carlo Crosti; Pier Luigi Meroni; Massimo Cugno
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 7.  Neutrophilic dermatoses: a review of current treatment options.

Authors:  Philip R Cohen
Journal:  Am J Clin Dermatol       Date:  2009       Impact factor: 7.403
  7 in total
  2 in total

1.  Systematic Review: Sweet Syndrome Associated with Inflammatory Bowel Disease.

Authors:  Joseph Sleiman; Asif A Hitawala; Benjamin Cohen; Katie Falloon; Marian Simonson; Benjamin Click; Urmi Khanna; Anthony P Fernandez; Florian Rieder
Journal:  J Crohns Colitis       Date:  2021-11-08       Impact factor: 9.071

Review 2.  Learning From Success and Failure: Biologics for Non-approved Skin Diseases.

Authors:  Reinhart Speeckaert; Jo Lambert; Nanja van Geel
Journal:  Front Immunol       Date:  2019-08-08       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.